BOSTON--(BUSINESS WIRE)--Invetx, a pioneering animal health biopharmaceutical company, today announced a $15 million Series A financing and founding collaborations with WuXi Biologics and AbCellera.
SOUTH SAN FRANCISCO, Calif. & BOSTON, Mass.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA ...
SOUTH SAN FRANCISCO, Calif. & BOSTON--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its ...
VANCOUVER, British Columbia & BOSTON — AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease ...
CAMBRIDGE, Mass., Feb. 3, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM), announced today that it has entered into ...
BOSTON--(BUSINESS WIRE)--Invetx, a pioneer in protein-based therapeutics for animal health, today announced that it has raised $60.5 million in an oversubscribed Series B financing. The investment was ...
Collaboration leverages Absci's leading generative AI Drug Creation models to design a novel antibody Half-Life Extension (HLE) platform for animal health applications VANCOUVER, Wash. and BOSTON, Jan ...
BOSTON--(BUSINESS WIRE)--Invetx Inc., a pioneer in protein-based therapeutics for animal health, announced today that it has agreed to be acquired by Dechra Pharmaceuticals Limited (Dechra), a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results